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Background: Multidrug-resistant Acinetobacter baumannii (MDRAB) is associated with nosocomial infections
worldwide. To date, the use of a phage to prevent infections caused by MDRAB has not been demonstrated.
Results: The MDRAB-specific phage ϕAB2 was stable at 4°C and pH 7 in 0.5% chloroform solution, and showed a
slight decrease in plaque-forming units (PFU)/ml of 0.3–0.9 log after 330 days of storage. The addition of ϕAB2 at a
concentration of at least 105 PFU/ml to an A. baumannii M3237 suspension killed >99.9% of A. baumannii M3237
after 5 min, regardless of A. baumannii M3237 concentration (104, 105, or 106 colony-forming units (CFU)/ml). The
addition of ϕAB2 at a concentration of 108 PFU/slide (>107 PFU/cm2) to glass slides containing A. baumannii M3237
at 104, 105, or 106 CFU/slide, significantly reduced bacterial numbers by 93%, 97%, and 99%, respectively. Thus, this
concentration is recommended for decontamination of glass surfaces. Moreover, infusion of ϕAB2 into 10% glycerol
exhibited strong anti-MDRAB activity (99.9% reduction), even after 90 days of storage. Treatment of a 10% paraffin
oil-based lotion with ϕAB2 significantly reduced (99%) A. baumannii M3237 after 1 day of storage. However, ϕAB2
had no activity in the lotion after 1 month of storage.
Conclusions: Phages may be useful for reducing MDRAB contamination in liquid suspensions or on hard surfaces.
Phages may also be inoculated into a solution to produce an antiseptic hand wash. However, the phage
concentration and incubation time (the duration of phage contact with bacteria) should be carefully considered to
reduce the risk of MDRAB contamination.
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Acinetobacter baumannii is a Gram-negative coccoba-
cillus frequently associated with nosocomial infections
worldwide [1,2]. It is an opportunistic pathogen with a
wide spectrum of clinical manifestations, including
pneumonia, meningitis, and blood stream, urinary tract,
and wound infections [3,4]. A. baumannii has developed
resistance to broad-spectrum antibiotics and has thus
become problematic in intensive care units (ICUs) [5].
In Taiwan, the first multidrug-resistant A. baumannii
(MDRAB) strain was identified in 1998 [6]. This strain* Correspondence: tsengcc@mail.tcu.edu.tw
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reproduction in any medium, provided the orwas among the top three pathogens causing nosocomial
infections in ICUs in Taiwan from 2003–2009 [7], and
the incidence of MDRAB infections worldwide has con-
tinued to increase [5,8-10].
Nosocomial MDRAB infections are usually transmit-
ted between patients by contaminated health-care
personnel [11]. Therefore, there is growing interest in
controlling the spread of MDRAB caused by health-care
workers, contaminated equipment, and ICU environ-
ments through disinfection methods. To date, several
disinfection techniques have been evaluated for inacti-
vating A. baumannii, including pasteurization [12],
ultraviolet light [13], chemical sanitizers [14-16], ozone
[17], and photocatalysis [18]. These sterilization tech-
niques are highly effective in reducing A. baumanniitd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Adsorption of ϕAB2 to A. baumannii M3237 and A.
baumannii ATCC 17978. Approximately 95% of the phage particles
were adsorbed onto the cells at 5 min and 100% were adsorbed at
10 min post-infection.
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face materials in the ICU environment. Moreover, exten-
sive use of chemicals can cause bacteria to develop
resistance to chemical sanitizers [16,19]. For example,
the growth and virulence of MDRAB are enhanced fol-
lowing exposure to ethanol and alcohol-based hand rubs
[20]. Thus, there is an immediate need to develop alter-
native strategies for preventing the spread of MDRAB.
Bacteriophages (phages) are natural parasites of bac-
teria and are extremely host-specific. Therefore, the use
of phages to reduce the concentration of specific bacter-
ial foodborne pathogens has gained increasing attention
[21-24]. For example, phages have been used to treat
foods contaminated with strains of Campylobacter [22],
Enterobacter [25], Escherichia coli O157 [26], Listeria
[23], Salmonella [27], and Staphylococcus [28,29]. The
levels of these bacterial pathogens have been successfully
reduced by 1–5 logs, depending upon the method used.
Moreover, the United States Food and Drug Administra-
tion has already approved the use of a Listeria-specific
phage, Listex P100, for food preservation [30]. Although
these studies suggest that bacteriophages might be highly
effective in reducing MDRAB levels, this has not been
studied in detail.
Although phages can significantly reduce the amount
of pathogenic bacteria in liquid foods [22-24], the use of
phages to reduce the levels of bacteria on hard surfaces
has rarely been studied. Culture-positive swab samples
of MDRAB have been recovered from frequently
touched surfaces in ICUs [14,31]. These observations in-
dicate the possible role of environmental surfaces in the
spread of MDRAB [32]. Liquid suspensions containing a
high concentration of phages allow the free diffusion of
phages to ensure contact with their specific host [23].
However, for hard surfaces, an uneven and large surface
area may limit the distribution of phage particles and de-
crease their ability to reach their bacterial targets [26].
This is especially true for low concentrations of bacteria
that are unevenly distributed in the environment [33].
Therefore, the effects of phage concentration, host cell
concentration and incubation time (the duration of
phage contact with bacteria) on the degree of biocontrol
on hard surfaces should be further investigated.
Despite intensive programs to encourage hand wash-
ing by health-care personnel, there is still a high rate of
MDRAB transmission in ICUs. O’Flaherty [34] demon-
strated the inclusion of phage K in an oil-based cream
killed Staphylococcus aureus on agar and in broth cul-
tures. Thus, a phage-containing hand cream could re-
duce pathogenic bacteria [34]. However, that study did
not report on the stability of phages in the cream or on
the exact degree of the bactericidal effect achieved. If a
phage-containing cream were feasible for infection con-
trol, this approach would likely reduce the transmissionof MDRAB from the hands of health-care personnel to
patients in ICUs.
The first lytic phage shown to specifically infect
MDRAB was characterized in 2010 [35] and belonged to
the Podoviridae family, with a broad host range amongst
MDRAB strains. This is the only known phage capable
of infecting A. baumannii ATCC17978, whose genome
has been fully sequenced [35]. In addition, ϕAB2 can
rapidly adsorb to its host and has a large burst size [35].
These advantages make ϕAB2 a good model phage for
controlling the prevalence of nosocomial infections
caused by MDRAB. To our knowledge, most biocontrol
studies have focused on using phages as food decon-
taminants [21,23,26,36,37]. The application of a phage as
a disinfectant agent for the control of MDRAB has not
been previously reported. Consequently, this study
aimed to evaluate the ability of ϕAB2 phage to re-
duce MDRAB in suspension and on experimentally-
contaminated glass surfaces. In addition, the ability of
ϕAB2 in a paraffin oil-based lotion or glycerol to reduce
the number of viable MDRAB was determined. The
stability of ϕAB2 under different environments (tem-
perature, pH, chloroform, and glass surface) was also
evaluated.Results
Adsorption and one-step growth curve of ϕAB2
ϕAB2 rapidly was adsorbed onto both A. baumannii
M3237 and A. baumannii ATCC 17978 (Figure 1). Within
5 min, greater than 95% of the phage particles were
adsorbed to A. baumannii M3237 and A. baumannii
ATCC 17978, and nearly 100% were adsorbed by 10 min.
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Figure 2A shows the stability of ϕAB2 stored in de-
ionized water at −20°C, 4°C, and 25°C, over 360 days.
When the phages were stored in deionized water at
−20°C, 25°C, and 4°C for 360 days they retained 0.6%,
1.0%, and 66.0% of infectivity, respectively. Although
ϕAB2 had infectivity retention of more than 50%
when stored in deionized water after 360 days at 4°C,
infectivity retention of more than 50% was only ob-
served up to 220 days in samples stored at −20°C or
25°C. The effect of refreezing on phage survival dem-
onstrated that ϕAB2 was unstable when the sample
was frozen repeatedly, as greater than 99.9% of phages
lost infectivity after refreezing during a 360-day stor-
age period at −20°C.Effect of pH on ϕAB2 stability
The optimal pH for ϕAB2 stability was determined
(Figure 2B). ϕAB2 was relatively stable following 360-day
incubation at pH 7. Under these conditions, there was a
2-log decrease in ϕAB2 phage titers from the initial titer
of 108 PFU/ml. However, ϕAB2 titers decreased by over
5-logs after 180-day incubation at pH 4 or pH 11. In ex-
tremely acidic conditions, at pH 2, no ϕAB2 plaques were
identified after 10 min (data not shown). Thus, ϕAB2 is
unstable under extreme pH conditions.(A)
(B)
Figure 2 Stability of ϕAB2 under (A) temperature, (B) pH, (C) chlorofo
survival at the respective storage time. These experiments were repeated tEffect of chloroform concentration on ϕAB2 stability
ϕAB2 titers were reduced following exposure to chloro-
form concentrations of 0.5% and 2% (Figure 2C). For
phage purification, a chloroform concentration of 0.5–
2% (v/v) is typically used, thus the infectivity of ϕAB2
following exposure to 0.5% and 2% chloroform was in-
vestigated. ϕAB2 exposed to 0.5% chloroform retained
stable infectivity of greater than 20% following a 360-day
storage period. However, infectivity retention of ϕAB2
was only 5% following a 360-day storage period in 2%
chloroform (Figure 2C).
ϕAB2 stability on glass slides
Desiccation reduced the stability of ϕAB2 when spiked
onto a glass surface over a 65-day period (Figure 2D).
There was a 1-log decrease in ϕAB2 titers (initial phage
concentration of 108 PFU/slide) after 12 h on the glass
surface. Infectivity of ϕAB2 on a glass slide was 0.1%
after 7 days and 0.001% after 30 days. Thus, ϕAB2 could
survive on a dried glass surface for 2 months, although a
large reduction in ϕAB2 titers was observed.
Reduction of MDRAB by ϕAB2 in a liquid suspension
We next assessed the ability of ϕAB2 to reduce the con-
centration of A. baumannii M3237 in sterile water over
different incubation times (the duration of contact of the
phages with the hosts). The addition of ϕAB2 to a liquid(C)
(D)
rm, and (D) glass surface. The dotted line indicates no plaque
hree times and the data shown are the mean ± SEM.
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cidal effect in all test groups except the 5 min incubation
low dose group (103 PFU/ml) (Figure 3). The ϕAB2 bac-
tericidal effect showed a dose-response as the lowest con-
centration of ϕAB2 tested (103 PFU/ml) exhibited the
weakest bactericidal capability, which was 6,600-fold lower
than when higher phage concentrations (105 and 108
PFU/ml) were used (Figure 3A). The addition of 105 or
108 PFU/ml ϕAB2 reduced the number of A. baumannii
M3237 by at least 3-logs at all bacterial test concentrations
after 5 min. After 10 min incubation, the effect was even
greater, with at least a 4-log reduction in MDRAB survival
rates (Figure 3B and C). In addition, the mean reduction
in bacteria was greater when a higher initial bacterial con-
centration was used. Thus, the same concentration of
ϕAB2 had a stronger bactericidal effect when added to
high bacterial concentrations (105 and 106 CFU/ml) com-
pared with low bacterial concentrations (104 CFU/ml). All
control groups showed a 100% survival rate. In addition to
the phage and bacterial host concentrations, the incuba-
tion time was also important for the bactericidal effect.
Approximately 95% of phage particles adsorbed to host
cells within 5 min, and nearly 100% were adsorbed by 10
min (Figure 1). Therefore, we selected the 5 and 10 min
time points to test the bactericidal effect of ϕAB2 in sus-
pension. At a low phage concentration (103 PFU/ml), an
increase in the incubation time from 5 to 10 min resulted
in a mean decrease of survival rate of MDRAB between
1.5- and 1,700-fold. In contrast, at higher phage concen-
trations (105 PFU/ml and 108 PFU/ml) there was a mean
reduction of bacterial concentration of 1.4- to 7-fold when
the incubation time was increased from 5 to 10 min.
Bactericidal effect of ϕAB2 on a hard surface
The addition of ϕAB2 to a hard glass surface contami-
nated with A. baumannii M3237 had a bactericidal(A) (B)
Figure 3 Bactericidal effect of different concentrations: (A) 103 (B) 105
baumannii M3237 in a liquid suspension, at incubation times of 5 and
These experiments were repeated three times, and the data shown are theeffect under some conditions (Figure 4). Phage concen-
trations of 103 and 105 PFU/slide caused a significant re-
duction (p < 0.05, 40% reduction) of A. baumannii
M3237 cells (104 and 105 CFU/slide) after 10 min
(Figure 4A and B). When a phage concentration of 108
PFU/slide was used, the number of A. baumannii
M3237 was significantly reduced (p < 0.05, >90% reduc-
tion) after 5 or 10 min for all concentrations of bacteria
tested (Figure 4C). However, the bactericidal effect of
ϕAB2 at 108 PFU/slide was significantly lower for A.
baumannii M3237 at 104 and 105 CFU/slide than at 106
CFU/slide (p < 0.05). To date, there is no standard
method for evaluating phage biocontrol efficiency on a
hard surface. Incubation times of 5 and 10 min were
chosen for surface tests on the basis of ϕAB2 adsorption
data (Figure 1) and a previous study by Abuladze et al.
[26]. Extending the incubation time from 5 to 10 min in-
creased the mean bactericidal effect on A. baumannii
M3237 1.3-fold under all test conditions.
Use of ϕAB2 as a hand sanitizer in a paraffin oil-based
lotion
The stability of ϕAB2 in a lotion and its ability to kill A.
baumannii M3237 when spread on agar (at a volume of
0.1 ml), were evaluated to determine the potential of
ϕAB2 as a hand lotion antiseptic. Prior to the addition
of the phage lotion, lysogeny broth (LB) agar was pre-
contaminated with approximately 5 × 101, 5 × 102, or 5 ×
103 CFU/ml (coefficient variation % (CV%) = 3.0%) of A.
baumannii M3237 (Figure 5). The initial phage concen-
tration in the lotion was 108 PFU/ml; however, this con-
centration decreased by approximately 98% after 10 days
of storage (p < 0.05). Phage lotion stored for 1 day sig-
nificantly reduced (p < 0.05) viable A. baumannii M3237
at initial concentrations of 101, 102 and 103 CFU/ml on
agar, by 97.6%, 99.8%, and 99.9%, respectively. Lotion(C)
, and (C) 108 PFU/ml of ϕAB2 on different concentrations of A.
10 min. The survival rate was calculated as in the Methods section.
mean ± SEM. *p < 0.05 compared with the respective control group.
(A) (B) (C)
Figure 4 Bactericidal effect of different concentrations: (A) 103 (B) 105, and (C) 108 PFU/slide of ϕAB2 on different concentrations of
A. baumannii M3237 on a glass surface following incubation times of 5 and 10 min. The survival rate was calculated as in the Methods
section. These experiments were repeated three times, and the data shown are the mean ± SEM. *p < 0.05 compared with respective control
group.
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concentration of viable A. baumannii M3237 by 92%,
88%, and 90%, respectively. Lotion stored for longer than
5 days could not effectively reduce the A. baumannii
M3237 concentration. Spreading a larger volume (0.5
ml) of lotion on agar did not significantly alter the num-
ber of A. baumannii M3237 killed by the phage, as com-
pared with a smaller volume (0.1 ml).
Use of ϕAB2 as a hand sanitizer in glycerol
Glycerol is used by the cosmetics industry to retain
moisture in the skin. Therefore, the addition of ϕAB2 to
glycerol may be an effective way to formulate a hand
sanitizer that can decrease MDRAB contamination and
retain moisture within the skin. Because the amount of
glycerol in cosmetic products varies (usually less than
20%), a concentration of 10% (v/v) glycerol was evalu-
ated in this study. Prior to the addition of the phage-(B)(A)
Figure 5 Bactericidal effect of 0.1 ml and 0.5 ml of ϕAB2-containing l
(B) 102, and (C) 103 CFU/ml of A. baumannii M3237 contaminated aga
*p < 0.05 compared with the respective control group.containing glycerol, LB agar was pre-contaminated with
approximately 5 × 101, 5 × 102, or 5 × 103 CFU/ml (CV%=
12.3%) of A. baumannii M3237 (Figure 6). The ϕAB2
phage concentration (108 PFU/ml) did not significantly
decrease (less than a 1-log decrease) when added to a gly-
cerol solution and stored for 90 days. The application of
phage-containing glycerol stored for 90 days to inoculated
agar significantly reduced (p < 0.05) the mean concentra-
tion of viable A. baumannii M3237 by 99.9%, regardless
of the initial bacterial concentration. After 180 days of
storage, ϕAB2 titers were decreased by approximately 2-
logs (p < 0.05). The application of phage-containing gly-
cerol stored for 180 days reduced the mean concentration
of viable A. baumannii M3237 by 62.4%, 86.2%, and
98.6% when the initial concentration of A. baumannii
M3237 was 101 CFU/ml, 102 CFU/ml, and 103 CFU/ml,
respectively. Similar to the effect observed with the lotion,
the bactericidal effect of spreading a larger volume (0.5 ml)(C)
otion (stored up to 30 days) on different concentrations: (A) 101
r. Phage titers (■) are shown on the right on the logarithmic scale.
(A) (B) (C)
Figure 6 Bactericidal effect of 0.1 ml and 0.5 ml of ϕAB2-containing glycerol (stored up to 180 days) on different concentrations:
(A) 101 (B) 102, and (C) 103 CFU/ml of A. baumannii M3237 contaminated agar. Phage titers (■) are shown on the right on the logarithmic
scale. *p < 0.05 compared with the respective control group. “100%” indicates 100% reduction in A. baumannii M3237 following application of
either 0.1 or 0.5 ml of ϕAB2-containing glycerol.
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nificantly different from that of a smaller volume (0.1 ml).
Discussion
To date, most biocontrol studies have used phages for
the decontamination of food and limited data are avail-
able concerning the stability of phages in an environ-
mental matrix. Furthermore, the use of a phage to
prevent infections caused by MDRAB has not been dem-
onstrated. The ϕAB2 phage was selected as a model
phage for this study because its DNA and protein pro-
files were previously determined [35]. The current study
demonstrated that phages such as the ϕAB2 phage
might be useful for reducing MDRAB contamination in
liquid suspensions or on hard surfaces such as may be
encountered in ICUs, and may be added to a solution to
produce an antiseptic hand wash.
One issue with the human use of phages is their po-
tential toxicity. Previously, we demonstrated ϕAB2 had
91–99% DNA sequence identity with the fully sequenced
ϕAB1 and that to date, no putative or confirmed toxin
genes have been identified in ϕAB2 [38]. In addition, no
prophage-related genes were observed in ϕAB1, al-
though Vallenet et al. suggested that putative prophage
sequences account for 5.1% and 6.7% of the genomes of
both A. baumannii strains [39]. Thus, it is reasonable to
assume that ϕAB2 has no toxin genes or prophage-
related genes, and we predict there will no safety issues
related to toxin production or chromosomal integration
of ϕAB2.
There have been limited studies regarding environ-
mental effects on phage stability. A previous study inves-
tigated another A. baumannii-specific phage, AB1,
which is relatively heat resistant and can survive temper-
atures of 50–60°C, and even a 15-min incubation at
90°C [40]. The stability of ϕAB2 at extremely hightemperatures was not evaluated in the present study be-
cause ϕAB2 is proposed for use as an alternative
sanitizer, so information regarding its stability for long
storage periods at refrigerated or freezing temperatures
was more relevant. Our study demonstrated that phage
infectivity is strongly dependent on environmental con-
ditions such as temperature, pH, and the presence of
other organic substances. Investigation of the optimal
pH for maintaining ϕAB2 infectivity demonstrated that
the least damaging pH tested was pH 7, similar to the
sewage from which ϕAB2 was isolated (pH 7.8). Yang et
al. also demonstrated that the AB1 phage was most
stable at pH 6, and that less than 42.9% of AB1 phages
lost their infectivity in a range between pH 5–9 [40].
Thus, our environmental stability results indicated that
ϕAB2 should be stored in a pH 7 solution at 4°C for ex-
tended storage if ϕAB2 is incorporated into a detergent.
Because MDRAB survives for long periods on environ-
mental surfaces and may promote cross-transmission,
we investigated the efficiency of ϕAB2 in reducing A.
baumannii M3237 contamination on surfaces. We ob-
served the ϕAB2 concentration required to reduce A.
baumannii M3237 contamination was lower for liquid
suspensions than hard surfaces. The mean survival rate
ratio of A. baumannii M3237 between surface and liquid
suspension ranged from 2–10,151 depending on the
phage concentration. As ϕAB2 does not diffuse as freely
on a hard surface as in a suspension, a higher concentra-
tion of ϕAB2 was required for surface decontamination
of MDRAB compared with in solution.
The ability of phages to persist on a surface for ex-
tended periods is limited by many factors, such as desic-
cation [37], which may explain the loss of ϕAB2
infectivity after 2 months storage on a glass surface. Be-
cause ϕAB2 cannot survive for long periods on a hard
surface, the phage detergent must be frequently re-
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MDRAB activity.
Previous biocontrol studies suggested that high phage
numbers should be used without relying on phage amp-
lification [22,23]. Although ϕAB2 has a larger burst size
than other phages [23,35], it is important to determine
the optimal phage concentration that will allow efficient
phage attachment and amplification for the quantity of
MDRAB present. Experiments on environmental ICU
samples have identified A. baumannii on 39% of the
sampled surfaces with a mean A. baumannii DNA con-
centration of 19,696 copies [39]. Based on the results of
our surface evaluation, we recommend that a phage con-
centration of at least 107 PFU/cm2 be applied to surfaces
in ICUs. This approach may not be suitable for the treat-
ment of large surfaces, but may be useful for small bio-
medical devices. Abuladze et al. suggested a glass matrix
is easier to decontaminate than gypsum [26]. Thus, the
phage decontamination efficiency for different surfaces
such as gypsum, plastic, Teflon, or other polymers may
vary, and requires further investigation. In addition to
phage concentration, the incubation time is also critical
for surface applications. When a high phage concentra-
tion (108 PFU/slide) was used to treat a surface contami-
nated with bacteria at a concentration of 105 CFU/slide,
an incubation time of 5 min resulted in a 96% reduction
of A. baumannii M3237 numbers. This incubation time
was caused a 94% reduction in the number of Escherichia
coli O157:H7 [26] under the same test conditions.
MDRAB can be transmitted via the hands of health-
care personnel. However, frequent or improper hand
washing can cause skin to lose moisture or become irri-
tated, reducing the hand washing rate despite intensive
hand washing educational programs. Therefore, the
addition of paraffin oil and glycerol to the formulation
of antiseptic hand wash might retain skin moisture and
reduce the transmission of MDRAB from the hands of
health-care workers to patients. Alcohol-based hand
rubs could reduce skin irritation [41] and reduce the
number of bacteria more effectively than soap and water
in a number of experimental models [42,43]. However,
A. baumannii may metabolize low levels of alcohol to
become more virulent [20]. Thus, an alternative hand
washing approach is required to prevent microorganisms
becoming tolerant to alcohol-based disinfectants in the
future.
In this study, we designed two antiseptic hand wash
experiments and observed a difference in the bactericidal
effect between phage-containing lotion and glycerol so-
lution, possibly related to the stability of ϕAB2 in differ-
ent media. Because the detailed compositions of
commercial creams are proprietary, it is difficult to ex-
plain the unpredictable changes of phage numbers in the
cream, as phages could aggregate, disaggregate, or decayafter long storage periods. O’Flaherty et al. demonstrated
that S. aureus-specific phage K exhibited antibacterial
activity when incorporated into a bismuth-based cream
[34]. The bismuth cream exhibited well antibacterial ac-
tivity, but the related phage stability was not reported. In
contrast, we observed that ϕAB2 was stable in 10% gly-
cerol after 90 days storage at room temperature. Gly-
cerol is a common cryoprotectant for phage infectivity
during storage at temperatures between −20 and −70°C.
Other phages, including F-specific RNA bacteriophages,
and Bacteroides fragilis-specific phages, are also stable in
10% glycerol for up to 50 days [44] and can retain their
infectivity with even longer storage times.
Conclusions
Since the introduction of antibiotics for clinical use,
antibiotic-resistant bacteria, such as MDRAB, have
emerged as important nosocomial pathogens worldwide.
Our study used ϕAB2 as a model phage to demonstrate
its potential for the prevention of nosocomial MDRAB
infections. As MDRAB are resistant to almost all cur-
rently available antibiotics and sanitizers, phages rep-
resent an alternative environmental decontamination
approach. Although some studies have focused on isolat-
ing and characterizing new phages with a broader host
range, further information regarding the stability of
phages in different environments is required before these
phages are used in hospitals. While phages could be
used to decontaminate environmental surfaces naturally
contaminated by MDRAB, when bacterial cell numbers
are low and the surface area is large, a high phage con-
centration (>107 PFU/cm2) is required to ensure contact
between phages and their hosts. This study demon-
strated that high concentrations of phages might be in-
oculated into a lotion or glycerol and used as an
antiseptic hand wash. However, the phage concentration
and incubation time should be carefully determined to
identify the optimal bactericidal effect on MDRAB.
Methods
Bacterial host strain and culture
We used A. baumannii M3237 as a bacterial host, instead
of an antibiotic-sensitive strain such as A. baumannii
ATCC 17978, for practical simulation of the bactericidal
effect of ϕAB2 on MDRAB in a hospital environment. A.
baumannii M3237was purchased from the Bioresource
Collection and Research Center of Taiwan (BCRC 80276).
A. baumannii M3237 is a MDRAB clinical isolate from
the Buddhist Tzu-Chi General Hospital and was
maintained and grown in LB or agar at 37°C.
Phage preparation
ϕAB2 was isolated from the raw sewage of a local hos-
pital [35]. A high-titer stock of phage ϕAB2 (109–1010
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lysis and elution. ϕAB2 was propagated and assayed in
triplicate using the double-agar-layer method as previ-
ously described [45].
Phage adsorption assay
A. baumannii M3237 was infected with phage ϕAB2 at
a multiplicity of infection (MOI; phage concentration/
bacterial concentration) of 0.001 and incubated at room
temperature. The bacterial host A. baumannii ATCC
17978 was also evaluated for comparison. Samples (100 μl)
were taken at 2-min intervals for 10 min, diluted in 0.9 ml
of cold LB, centrifuged (12,000 × g, 5 min), and super-
natants containing unadsorbed phages were titrated.
Effect of temperature on ϕAB2 stability
ϕAB2 stock (1010 PFU/ml) was diluted to 108 PFU/ml
with distilled water. The mixed phage solution was sub-
sequently divided into 1 ml vials and stored at −20°C, 4°C,
or 25°C. At various time points up to 360 days, solution
from one vial at each temperature was inoculated for
plaque assay. Used vials were discarded. To assess the ef-
fect of refreezing on phage survival, a vial with 500 ml of a
108 PFU/ml phage solution was stored at −20°C and inoc-
ulated for plaque assays at various time points, after which
the solution was stored at −20°C again until the next sam-
pling time.
Effect of pH on ϕAB2 stability
The stability of ϕAB2 at different pH values was deter-
mined by mixing 1010 PFU/ml of ϕAB2 suspension with
sterile water at different pH values (pH 2, 4, 7, or 11) to
obtain a 100 ml phage solution with a final phage con-
centration of 108 PFU/ml. The pH was adjusted with 1 N
HCl or KOH. After phage solutions were prepared, the
initial concentration was determined within 5 min, and
then stored at 25°C until used.
Effect of chloroform concentration on ϕAB2 stability
Briefly, phage solutions (108 PFU/ml) were exposed to
0.5% or 2% chloroform. The first sample was inoculated
within 5 min to determine the initial concentration, and
the solution was then inoculated for plaque assays at dif-
ferent storage times up to 360 days.
Stability of ϕAB2 on glass slides
Aliquots of 100 μl of a 109 PFU/ml ϕAB2 suspension
were spiked on the surface of sterilized glass slides (108
PFU/13.8 cm2 surface), and incubated in a biosafety
hood at room temperature for 30 min until completely
dry. At various time points, a spiked glass slide was
placed into a conical tube with 20 ml of peptone and
gently vortexed for 30 s. ϕAB2 recovered in the eluant
was enumerated by plaque assay. All desiccationexperiments were performed at room temperature (25°C)
and 55–65% relative humidity.
Bactericidal effect of ϕAB2 in a liquid suspension
To determine the bactericidal effect of ϕAB2 in suspen-
sion, A. baumannii M3237 was cultured overnight and
then transferred to a flask and incubated at 37°C until
reaching an OD600 of 1.0 (5 × 10
8 CFU/ml). A. baumannii
M3237 cultures were then serially diluted to obtain
final concentrations of 5 × 106, 5 × 105 or 5 × 104 CFU/ml.
A 1 ml aliquot of each concentration was mixed with 1 ml
of ϕAB2 suspension to obtain a final phage concentration
of 103, 105, or 108 PFU/ml. Phage-free culture (containing
bacteria only) was included as a control. Following a 5- or
10-min incubation, host and phage mixtures were imme-
diately passed through 47-mm diameter membrane filters
(pore size of 0.45 μm, Pall Corporation) and washed with
20 ml of phosphate-buffered saline (PBS) to remove
unattached phages [26]. Washed filters were placed in sep-
arate dishes containing LB agar, and following 24-h incu-
bation at 37°C, the number of recovered A. baumannii
M3237 was calculated by counting colonies on each filter.
The survival rate was calculated as log10 of Nt/N0, where
N0 is the number of A. baumannii M3237 colonies recov-
ered on the control filter and Nt is the number of colonies
on the test filter.
Bactericidal effect of ϕAB2 on a glass slide
To determine the bactericidal effect of ϕAB2 on a glass
surface, glass slides were sterilized, pre-contaminated
with A. baumannii M3237 by spreading diluted culture
stock solution on the glass surface to obtain concen-
trations of 104, 105, and 106 CFU/slide and dried for
30 min in a biosafety hood at room temperature. Then,
slides were divided into two groups. 1) test: treated with
ϕAB2 to reach a concentration of 103, 105, or 108 PFU/
slide and 2) control: treated with phage-free suspension.
After the ϕAB2 solution or phage-free suspension was
applied to the A. baumannii M3237 slide, they were
stored for 5 or 10 min at room temperature. Residual A.
baumannii M3237 particles on the test or control slides
were eluted with 20 ml of peptone into a conical tube,
gently vortexed for 30 s, serially diluted and passed
through membrane filters, as above. The filters were
then washed with PBS, placed on LB agar plates, and in-
cubated for 24 h at 37°C. The number of A. baumannii
M3237 colonies that grew on each filter was counted
and the survival rate was calculated.
Production of ϕAB2 hand sanitizer in a paraffin oil-based
lotion
A commercial cream containing paraffin mineral oil
(First Chemical Works, Taipei, Taiwan) was combined
with ϕAB2 in a conical tube and sterile water added to
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tion of 10% (v/v) paraffin oil and a phage concentration
of 108 PFU/ml. The phage-containing lotion was stored
at room temperature up to 30 days. At each sampling
point, the phage lotion was inoculated for plaque assays
to obtain a kinetic curve of the phage concentration.
The relationship between the number of residual
ϕAB2 phages in the lotion and their ability to inhibit
MDRAB was evaluated. At each sampling point, LB agar
was pre-contaminated with A. baumannii M3237 sus-
pension to obtain surface concentrations of 5 × 101, 5 ×
102, and 5 × 103 CFU/ml. Contaminated agar plates
were dried for 30 min in a biosafety hood at room
temperature and divided into two groups: test agars re-
ceived 0.1 or 0.5 ml of the phage-containing lotion to
simulate the volumes of lotion used by most hand cream
consumers and control. The control agars consisted of a
phage-free lotion. The test and control agars were then
incubated for 24 h at 37°C, and bacterial recovery counts
calculated by comparing the number of A. baumannii
M3237 colonies from the test agars with those from the
control agars.
ϕAB2 in glycerol as a hand sanitizer
Briefly, the phage stock was mixed with glycerol to ob-
tain a solution of 10% (v/v) glycerol/108 PFU/ml phage
and stored at room temperature for up to 180 days to
obtain a kinetic curve of the phage variation during
this period. Phage stability and ability to inhibit A.
baumannii M3237 was determined as described above
for lotions.
Statistical analysis
Statistical analyses were performed using SPSS, version
17.0 (SPSS Institute Inc., Chicago, IL, USA). Measure-
ment of ϕAB2 bactericidal effect in liquid suspensions
and glass slides, comparison of A. baumannii M3237
survival rates with different incubation times and control
sets and reduction of viable A. baumannii M3237 by
ϕAB2 lotion or glycerol was performed using one-way
ANOVA, followed by Tukey’s test.
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